Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-12-14 Sale |
2022-12-16 5:00 pm |
Ventyx Biosciences Inc. | VTYX | Sandborn William J. See Remarks |
42,682 | $33.87 | $1,445,718 | 118,747 (Indirect Direct) |
View |
| 2022-12-13 Sale |
2022-12-15 5:00 pm |
Ventyx Biosciences Inc. | VTYX | Krueger Christopher W Chief Business Officer |
30,000 | $34.46 | $1,033,668 | 272,692 (Direct) |
View |
| 2022-12-13 Sale |
2022-12-15 5:00 pm |
Ventyx Biosciences Inc. | VTYX | Nuss John Chief Scientific Officer |
35,000 | $34.32 | $1,201,078 | 223,696 (Direct) |
View |
| 2022-12-02 Sale |
2022-12-06 5:00 pm |
Ventyx Biosciences Inc. | VTYX | Mohan Raju Chief Executive Officer |
300,000 | $28.97 | $8,691,087 | 1,541,811 (Direct) |
View |
| 2022-12-02 Sale |
2022-12-06 5:00 pm |
Ventyx Biosciences Inc. | VTYX | Auster Martin Chief Financial Officer |
97,647 | $29.01 | $2,832,603 | 378,833 (Direct) |
View |
| 2022-12-02 Sale |
2022-12-06 5:00 pm |
Ventyx Biosciences Inc. | VTYX | Krueger Christopher W Chief Business Officer |
50,000 | $29.01 | $1,450,730 | 302,692 (Direct) |
View |
| 2022-12-05 Sale |
2022-12-06 5:00 pm |
Ventyx Biosciences Inc. | VTYX | Nuss John Chief Scientific Officer |
50,000 | $28.23 | $1,411,311 | 258,696 (Direct) |
View |
| 2022-11-30 Sale |
2022-12-02 5:33 pm |
Ventyx Biosciences Inc. | VTYX | NSV Partners III LP NSV Partners III GP LLC 10% Owner |
272,545 | $29.01 | $7,906,882 | 16,616,048 (Indirect) |
View |
| 2022-11-30 Sale |
2022-12-02 5:32 pm |
Ventyx Biosciences Inc. | VTYX | Subramaniam Somu Director 10% Owner |
272,545 | $29.01 | $7,906,882 | 16,616,048 (Indirect) |
View |
| 2022-11-07 Sale |
2022-11-09 6:32 pm |
Ventyx Biosciences Inc. | VTYX | NSV Partners III LP NSV Partners III GP LLC 10% Owner |
3,935 | $29.08 | $114,427 | 16,888,593 (Indirect) |
View |
| 2022-11-07 Sale |
2022-11-09 5:05 pm |
Ventyx Biosciences Inc. | VTYX | Subramaniam Somu Director 10% Owner |
3,935 | $29.08 | $114,427 | 16,888,593 (Indirect) |
View |
| 2021-10-25 Purchase |
2021-10-27 4:04 pm |
Ventyx Biosciences Inc. | VTYX | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund III LP Former 10% Owner |
625,000 | $16 | $10,000,000 | 1,410,303 (Indirect) |
View |
| 2021-10-25 Purchase |
2021-10-25 7:40 pm |
Ventyx Biosciences Inc. | VTYX | venBio Global Strategic Fund III L.P. VENBIO GLOBAL STRATEGIC GP III L.P. VENBIO GLOBAL STRATEGIC GP III LTD Adelman Robert J GOODMAN COREY S See Remarks 10% Owner |
312,500 | $16 | $5,000,000 | 5,011,536 (Indirect Direct) |
View |
| 2021-10-25 Purchase |
2021-10-25 6:42 pm |
Ventyx Biosciences Inc. | VTYX | Royston Aaron Director 10% Owner |
312,500 | $16 | $5,000,000 | 5,011,536 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-12-14 Exercise |
2022-12-16 5:00 pm |
2021-02-26 2031-02-26 |
Ventyx Biosciences Inc. | VTYX | Sandborn William J. See Remarks |
42,682 | $0 | 118,747 (Direct) |
View |
| 2022-12-14 Exercise |
2022-12-16 5:00 pm |
N/A N/A |
Ventyx Biosciences Inc. | VTYX | Sandborn William J. See Remarks |
2,391 | $3.54 | 118,747 (Direct) |
View |
| 2022-12-14 Exercise |
2022-12-16 5:00 pm |
N/A N/A |
Ventyx Biosciences Inc. | VTYX | Sandborn William J. See Remarks |
3,189 | $1.73 | 118,747 (Direct) |
View |
| 2022-12-14 Exercise |
2022-12-16 5:00 pm |
N/A N/A |
Ventyx Biosciences Inc. | VTYX | Sandborn William J. See Remarks |
37,102 | $0.2 | 118,747 (Direct) |
View |
| 2022-12-13 Other |
2022-12-15 9:11 pm |
N/A N/A |
Ventyx Biosciences Inc. | VTYX | NSV Partners III LP NSV Partners III GP LLC NSV Investments I L.P. 10% Owner |
3,341,262 | $0 | 16,616,048 (Indirect) |
View |
| 2022-12-13 Other |
2022-12-15 9:09 pm |
N/A N/A |
Ventyx Biosciences Inc. | VTYX | Subramaniam Somu Director 10% Owner |
3,341,262 | $0 | 16,616,048 (Indirect) |
View |
| 2022-12-02 Exercise |
2022-12-06 5:00 pm |
N/A 2031-05-06 |
Ventyx Biosciences Inc. | VTYX | Auster Martin Chief Financial Officer |
50,000 | $0 | 378,833 (Direct) |
View |
| 2022-12-02 Exercise |
2022-12-06 5:00 pm |
N/A N/A |
Ventyx Biosciences Inc. | VTYX | Auster Martin Chief Financial Officer |
50,000 | $3.45 | 378,833 (Direct) |
View |
| 2022-08-23 Exercise |
2022-08-24 8:16 pm |
N/A 2029-03-27 |
Ventyx Biosciences Inc. | VTYX | Krueger Christopher W Chief Business Officer |
169,361 | $0 | 376,887 (Direct) |
View |
| 2022-08-23 Exercise |
2022-08-24 8:16 pm |
N/A N/A |
Ventyx Biosciences Inc. | VTYX | Krueger Christopher W Chief Business Officer |
169,361 | $0.2 | 376,887 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 6:22 pm |
N/A 2032-06-09 |
Ventyx Biosciences Inc. | VTYX | venBio Global Strategic Fund III L.P. VENBIO GLOBAL STRATEGIC GP III L.P. VENBIO GLOBAL STRATEGIC GP III LTD Adelman Robert J GOODMAN COREY S See Remarks 10% Owner |
26,602 | $0 | 26,602 (Indirect) |
View |
| 2022-06-09 Option Award |
2022-06-10 5:43 pm |
N/A 2032-06-09 |
Ventyx Biosciences Inc. | VTYX | Choksey Jigar Director |
13,301 | $0 | 13,301 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 5:42 pm |
N/A 2032-06-09 |
Ventyx Biosciences Inc. | VTYX | Subramaniam Somu Director |
13,301 | $0 | 13,301 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 5:42 pm |
N/A 2032-06-09 |
Ventyx Biosciences Inc. | VTYX | Royston Aaron Director |
13,301 | $0 | 13,301 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 5:41 pm |
N/A 2032-06-09 |
Ventyx Biosciences Inc. | VTYX | White William Richard Director |
13,301 | $0 | 13,301 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 5:40 pm |
N/A 2032-06-09 |
Ventyx Biosciences Inc. | VTYX | Gaster Richard Director |
13,301 | $0 | 13,301 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 5:39 pm |
N/A 2032-06-09 |
Ventyx Biosciences Inc. | VTYX | Gujrathi Sheila Director |
13,301 | $0 | 13,301 (Direct) |
View |
| 2022-05-09 Option Award |
2022-05-09 7:06 pm |
N/A 2032-05-09 |
Ventyx Biosciences Inc. | VTYX | Sandborn William J. See Remarks |
700,000 | $0 | 700,000 (Direct) |
View |
Ownership |
2022-05-09 08:23 am |
N/A N/A |
Ventyx Biosciences Inc. | VTYX | Sandborn William J. See Remarks |
0 | $0 | 161,429 (Direct) |
View |
| 2022-02-04 Option Award |
2022-02-04 6:42 pm |
N/A 2032-02-04 |
Ventyx Biosciences Inc. | VTYX | Auster Martin Chief Financial Officer |
145,000 | $0 | 145,000 (Direct) |
View |
| 2022-02-04 Option Award |
2022-02-04 6:39 pm |
N/A 2032-02-04 |
Ventyx Biosciences Inc. | VTYX | Nuss John Chief Scientific Officer |
145,000 | $0 | 145,000 (Direct) |
View |
| 2022-02-04 Option Award |
2022-02-04 6:38 pm |
N/A 2032-02-04 |
Ventyx Biosciences Inc. | VTYX | Drappa Jorn Chief Medical Officer |
145,000 | $0 | 145,000 (Direct) |
View |
| 2022-02-04 Option Award |
2022-02-04 6:32 pm |
N/A 2032-02-04 |
Ventyx Biosciences Inc. | VTYX | Krueger Christopher W Chief Business Officer |
145,000 | $0 | 145,000 (Direct) |
View |
| 2022-02-04 Option Award |
2022-02-04 6:27 pm |
N/A 2032-02-04 |
Ventyx Biosciences Inc. | VTYX | Mohan Raju Chief Executive Officer |
370,000 | $0 | 370,000 (Direct) |
View |
| 2021-12-17 Option Award |
2021-12-17 8:06 pm |
N/A 2031-12-17 |
Ventyx Biosciences Inc. | VTYX | Krueger Christopher W Chief Business Officer |
83,833 | $0 | 83,833 (Direct) |
View |
| 2021-12-17 Option Award |
2021-12-17 8:01 pm |
N/A 2031-12-17 |
Ventyx Biosciences Inc. | VTYX | Nuss John Chief Scientific Officer |
279,444 | $0 | 279,444 (Direct) |
View |
| 2021-12-17 Option Award |
2021-12-17 7:55 pm |
N/A 2031-12-17 |
Ventyx Biosciences Inc. | VTYX | Mohan Raju Chief Executive Officer |
933,345 | $0 | 933,345 (Direct) |
View |
| 2021-12-02 Option Award |
2021-12-03 4:17 pm |
N/A 2031-12-02 |
Ventyx Biosciences Inc. | VTYX | Gujrathi Sheila Director |
277,941 | $0 | 277,941 (Direct) |
View |
| 2021-10-25 Conversion |
2021-10-27 4:04 pm |
N/A N/A |
Ventyx Biosciences Inc. | VTYX | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund III LP Former 10% Owner |
1,570,606 | $0 | 1,410,303 (Indirect) |
View |
| 2021-10-25 Conversion |
2021-10-25 7:40 pm |
N/A N/A |
Ventyx Biosciences Inc. | VTYX | venBio Global Strategic Fund III L.P. VENBIO GLOBAL STRATEGIC GP III L.P. VENBIO GLOBAL STRATEGIC GP III LTD Adelman Robert J GOODMAN COREY S See Remarks 10% Owner |
7,369,538 | $0 | 5,011,536 (Direct) |
View |
| 2021-10-25 Conversion |
2021-10-25 6:49 pm |
N/A N/A |
Ventyx Biosciences Inc. | VTYX | NSV Investments I L.P. NSV Partners III LP NSV Partners III GP LLC 10% Owner |
33,785,056 | $0 | 16,892,528 (Indirect) |
View |
| 2021-10-25 Conversion |
2021-10-25 6:45 pm |
N/A N/A |
Ventyx Biosciences Inc. | VTYX | Subramaniam Somu Director 10% Owner |
33,785,056 | $0 | 16,892,528 (Indirect) |
View |
| 2021-10-25 Conversion |
2021-10-25 6:45 pm |
N/A N/A |
Ventyx Biosciences Inc. | VTYX | Gujrathi Sheila Director |
32,897 | $0 | 32,897 (Direct) |
View |
| 2021-10-25 Conversion |
2021-10-25 6:42 pm |
N/A N/A |
Ventyx Biosciences Inc. | VTYX | Royston Aaron Director 10% Owner |
7,369,538 | $0 | 5,011,536 (Indirect) |
View |